---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-028567"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-17T07:38:03.783410+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals raises $8.8M, announces HOPE Therapeutics launch and Rockefeller advisory role

## Summary
- Raised $8.8M gross from experienced biotech investors via common stock offering; no warrants or variable rate features.
- HOPE Therapeutics subsidiary to launch in September 2025 with flagship location in Palm Beach, FL.
- Clinics will combine ketamine, transcranial magnetic stimulation, hyperbaric oxygen for suicidal depression, PTSD, TBI.
- Matthew Rockefeller joins HOPE Therapeutics Advisory Board.

## SEC filing metadata
- accession: 0001437749-25-028567
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774925028567/0001437749-25-028567-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774925028567/nrxp20250908_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-028567
- JSON: https://secwatch.observer/filing/0001437749-25-028567.json
- Plain text: https://secwatch.observer/filing/0001437749-25-028567.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.